Many thousands of prostate cancer cases were missed during the disruption of the COVID pandemic. Those are the findings of a new study published in BJU International last month. Researchers from the University of Oxford and other U.K. universities analyzed a dataset of 285,160 participants from OpenSAFELY-TPP, a large, nationally representative dataset of routine health care records.
They focused on 165,410 men in the U.K. who had been diagnosed with prostate cancer between Jan. 2015 and July 2023. In 2020, diagnoses of prostate cancer dropped by 31% over the prior year. The decrease was 18% in 2021. By 2022, the diagnosed cases had returned to expected levels.
The delayed diagnoses in the U.K. are not surprising,' he added. The study did have some limitations, the researchers acknowledged. First, it focused only on data from England — so it does not apply to global populations. It is also possible that some cases were missed, as the diagnoses were pulled from primary care health records rather than cancer registries. 'However, in the U.K.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: FoxBusiness - 🏆 458. / 53 Read more »